is berberine a glp-1 receptor agonist RESEARCH WEDNESDAY has been described as “Nature's Ozempic” across social media. recent systematic review and meta-analysis combined data from 23 randomised controlled trials and found statistically significant reductions in GLP-1: Genetic Variants Related to

An exhaustive literature search was executed across three primary scientific databases: PubMed/MEDLINE, Scopus, and Web of Science

Many lazaroid derivatives have been developed that inhibit iron-dependent lipid peroxidation in brain cells in vitro , as well as show neuroprotective activity in various animal models of traumatic brain injury (TBI) and of the spinal cord

Any common side effects that patients may experience while taking GLP-1s, such as nausea, are manageable

This peptide has also been studied in relation to osteoblast activity, tibial development, and vertebral structure

Benefits were more pronounced in studies using 6001,200mg per day over at least eight weeks.2 A 2022 randomized controlled trial in patients with metabolic syndrome found that 600mg of ALA daily for 12 weeks significantly reduced triglyceride levels and total cholesterol compared to placebo.59 However, the study did not observe significant changes in LDL-C or HDL-C